North America Legal Cannabis Market Size, Share & Trends Report

North America Legal Cannabis Market Size, Share & Trends Analysis Report By Source (Marijuana, Hemp), By End-use (Recreational, Industrial, Medical Uses), By Derivative (CBD, THC), And Segment Forecasts, 2022 - 2030

  • Report ID: GVR-4-68039-828-0
  • Number of Pages: 110
  • Format: Electronic (PDF)
  • Historical Range: 2017 - 2020
  • Industry: Healthcare

Table of Contents

Chapter 1 Methodology and Scope
                   1.1 Research Process
                   1.2 Information Procurement
                       1.2.1 Purchased database
                           1.2.1.1 GVR’s internal database
                       1.2.2 Market Formulation & Validation
                   1.3 Research Methodology
                   1.4 Research Scope And Assumptions
                   1.5 Research Methodology
                       1.5.1 Region Market: CAGR Calculation
                           1.5.1.1 Region Based Segment Share Calculation
                   1.6 List To Data Sources
Chapter 2 Executive Summary
                   2.1 Market Summary
Chapter 3 North America Legal Cannabis Market: Variables, Trends & Scope
                   3.1 Market Segmentation
                   3.2 Penetration & Growth Prospect Mapping
                   3.3 Market Dynamics
                       3.3.1 Market Driver Analysis
                           3.3.1.1 Growing adoption of medical marijuana for treatment of chronic diseases
                           3.3.1.2 Elimination of black market through the legalization of medical marijuana
                       3.3.2 Market Restraint Analysis
                           3.3.2.1 High pricing of cannabis compared to illegal markets in the U.S.
                           3.3.2.2 Illicit cannabis trade due to surplus cultivation
                   3.4 Industry Analysis - SWOT Analysis, By Factor (Political & Legal, Economic, And Technological
                       3.4.1 Political And Legal Landscape
                       3.4.2 Economic And Social Landscape
                       3.4.3 Technology Landscape
                   3.5 Cannabis Market - Porter’s Analysis
                       3.5.1. Threat of New Entrants
                       3.5.2 Bargaining Power of Buyers
                       3.5.3 Competitive Rivalry
                       3.5.4 Bargaining Power of Suppliers
                       3.5.5 Threat of Substitutes
                   3.6 History of Medical Use of Cannabis in North America
                   3.7 History of Industrial Use of Cannabis in North America
                   3.8 North America Legal Cannabis Number of clinical trials
                   3.9 Legal Cannabis Industry: Legalization Timeline in North America
                       3.9.1 Legalization Landscape (Timeline)
                       3.9.2 The U.S. Legalization Landscape
                       3.9.3 The Canada Legalization Landscape
                       3.9.4 North America Legal Cannabis Regulatory Scenario, By Country
                       3.9.4.1 U.S.
                               3.9.4.1.1 Overview
                               3.9.4.1.2 Cultivation/Production
                               3.9.4.1.3 Regulatory Bodies Involved
                           3.9.4.2 Canada
                               3.9.4.2.1 Overview
                               3.9.4.2.2 Cultivation
                               3.9.4.2.3 Production
                               3.9.4.2.4 Regulatory Bodies Involved
                   3.10 North America Legal Cannabis Industry: Consumption Pattern Analysis
                       3.10.1 North America
                   3.11 Trade Opportunity Analysis, by region
                       3.11.1 North America
                   3.12 Legal Cannabis Industry: Country Case Study
                       3.12.1 U.S.
                           3.12.1.1 Legalization of Cannabis
                           3.12.1.2 Reason for Legalization
                           3.12.1.3 Scenario After Legalization and Consumer Attitude
                           3.12.1.4 Competitive Landscape Post Legalization
                       3.12.2 Canada
                           3.12.2.1 Legalization of Cannabis
                           3.12.2.2 Reason for Legalization
                           3.12.2.3 Scenario After Legalization
                           3.12.2.4 Consumer Attitudes Toward Legalization
                           3.12.2.5 Competitive Landscape Post Legalization:
                   3.13 Human Abuse Liability Experience in North America Cannabis Market
                   3.14 Qualitative analysis on synthetic cannabinoids and cannabis in North America
Chapter 4 North America Legal Cannabis Market: Source Estimates & Trend Analysis
                   4.1 North America Legal Cannabis Market: Source Movement Analysis
                   4.2 North America Legal Cannabis Market: Source Analysis
                       4.2.1 Hemp
                           4.2.1.1 Hemp Market Estimates and Forecasts, 2017 - 2030 (USD Million)
                           4.2.1.2 Hemp CBD
                               4.2.1.2.1 Hemp CBD Market Estimates and Forecasts, 2017 - 2030 (USD Million)
                           4.2.1.3 Supplements
                               4.2.1.3.1 Supplements Market Estimates and Forecasts, 2017 - 2030 (USD Million)
                           4.2.1.4 Industrial Hemp
                               4.2.1.4.1 Industrial Hemp Market Estimates and Forecasts, 2017 - 2030 (USD Million)
                       4.2.2 Marijuana
                           4.2.2.1 Marijuana Market Estimates and Forecasts, 2017 - 2030 (USD Million)
                           4.2.2.2 Flower
                               4.2.2.2.1 Flower Market Estimates and Forecasts, 2017 - 2030 (USD Million)
                           4.2.2.3 Oils and Tinctures
                               4.2.2.3.1 Oils and Tinctures Market Estimates and Forecasts, 2017 - 2030 (USD Million)
Chapter 5 North America Legal Cannabis Market: Derivatives Estimates & Trend Analysis
                   5.1 North America Legal Cannabis Market: Derivatives Movement Analysis
                   5.2 North America Legal Cannabis Market: Derivatives Analysis
                       5.2.1 CBD
                           5.2.1.1 CBD Market Estimates and Forecasts, 2017 - 2030 (USD Million)
                       5.2.2 THC
                           5.2.2.1 THC Market Estimates and Forecasts, 2017 - 2030 (USD Million)
                       5.2.3 Others
                           5.2.3.1 Others Market Estimates and Forecasts, 2017 - 2030 (USD Million)
Chapter 6 North America Legal Cannabis Market: End-use Estimates & Trend Analysis
                   6.1 North America Legal Cannabis Market: End Use Movement Analysis
                   6.2 North America Legal Cannabis Market: End Use Analysis
                       6.2.1 Recreational Use
                           6.2.1.1 Recreational Use Market Estimates and Forecasts, 2017 - 2030 (USD Million)
                       6.2.2 Medical Use
                           6.2.2.1 Medical Use Market Estimates and Forecasts, 2017 - 2030 (USD Million)
                           6.2.2.2 Chronic Pain
                               6.2.2.2.1 Chronic Pain Market Estimates and Forecasts, 2017 - 2030 (USD Million)
                           6.2.2.3 Cancer
                               6.2.2.3.1 Chemotherapy-Induced Nausea & Vomiting
                               6.2.2.3.2 Cancer Market Estimates and Forecasts, 2017 - 2030 (USD Million)
                           6.2.2.4 Depression and Anxiety
                               6.2.2.4.1 Depression and Anxiety Market Estimates and Forecasts, 2017 - 2030 (USD Million)
                           6.2.2.5 Arthritis
                               6.2.2.5.1 Arthritis Market Estimates and Forecasts, 2017 - 2030 (USD Million)
                           6.2.2.6 Diabetes
                               6.2.2.6.1 Diabetes Market Estimates and Forecasts, 2017 - 2030 (USD Million)
                           6.2.2.7 Glaucoma
                               6.2.2.7.1 Glaucoma Market Estimates and Forecasts, 2017 - 2030 (USD Million)
                           6.2.2.8 Migraines
                               6.2.2.8.1 Migraines Market Estimates and Forecasts, 2017 - 2030 (USD Million)
                           6.2.2.9 Epilepsy
                               6.2.2.9.1 Epilepsy Market Estimates and Forecasts, 2017 - 2030 (USD Million)
                           6.2.2.10 Multiple Sclerosis
                               6.2.2.10.1 Multiple Sclerosis Market Estimates and Forecasts, 2017 - 2030 (USD Million)
                           6.2.2.11 AIDS
                               6.2.2.11.1 AIDS Market Estimates and Forecasts, 2017 - 2030 (USD Million)
                           6.2.2.12 Amyotrophic Lateral Sclerosis (ALS)
                               6.2.2.12.1 ALS Market Estimates and Forecasts, 2017 - 2030 (USD Million)
                           6.2.2.13 Alzheimer’s
                               6.2.2.13.1 Alzheimer’s Market Estimates and Forecasts, 2017 - 2030 (USD Million)
                           6.2.2.14 Post Traumatic Stress Disorder (PTSD)
                               6.2.2.14.1 PTSD Market Estimates and Forecasts, 2017 - 2030 (USD Million)
                           6.2.2.15 Parkinson’s
                               6.2.2.15.1 Parkinson’s Market Estimates and Forecasts, 2017 - 2030 (USD Million)
                           6.2.2.16 Tourette’s
                               6.2.2.16.1 Tourette’s Market Estimates and Forecasts, 2017 - 2030 (USD Million)
                           6.2.2.17 Others
                               6.2.2.17.1 Others Market Estimates and Forecasts, 2017 - 2030 (USD Million)
                       6.2.3 Industrial Use
                           6.2.3.1 Industrial Use Market Estimates and Forecasts, 2017 - 2030 (USD Million)
Chapter 7 North America Legal Cannabis Market: Regional Estimates & Trend Analysis
                   7.1 North America Legal Cannabis Market: Region Movement Analysis, 2017 - 2030
                       7.1.1. North America
                           7.1.1.1 North America Legal Cannabis Market Estimates and Forecasts, 2017 - 2030 (USD Million)
                       7.1.2 U.S.
                           7.1.2.1 U.S. Legal Cannabis Market Estimates and Forecasts, 2017 - 2030 (USD Million)
                       7.1.3 Canada
                           7.1.3.1 Canada Legal Cannabis Market Estimates and Forecasts, 2017 - 2030 (USD Million)
Chapter 8 Competitive Analysis
                   8.1 Company Market Position Analysis
                   8.2 Recent Developments & Impact Analysis, By Key Market Participants
                   8.3 Company/Competition Categorization (Key Innovators, Market Leaders, Emerging Players)
                   8.4 List of Tobacco Companies Investing in Cannabis
Chapter 9 Competitive Landscape
                   9.1 Major Companies in The Ecosystem, By Various Parameters
                       9.1.1 Canopy Growth Corporation
                       9.1.2 GW Pharmaceuticals, plc
                       9.1.3 Aurora Cannabis
                       9.1.4 Aphria, Inc. (Prior to the merger with Tilray)
                       9.1.5 Cronos Group
                       9.1.6 Tilray
                       9.1.7 Sundial Growers
                       9.1.8 Insys Therapeutics, Inc.
                       9.1.9 Vivo Cannabis Inc.
                       9.1.10 Cara Therapeutics, Inc


List of Tables

TABLE 1 Major companies in the ecosystem, by funding, number of employees, headquarters, and business model
TABLE 2 Major companies in the ecosystem, by revenue, net loss, valuation, regions, etc.
TABLE 3 North America legal cannabis market, by country, 2017 - 2030 (USD Million)
TABLE 4 North America legal cannabis market, by sources, 2017 - 2030 (USD Million)
TABLE 5 North America legal marijuana market, by product, 2017 - 2030 (USD Million)
TABLE 6 North America hemp market, by product, 2017 - 2030 (USD Million)
TABLE 7 North America legal cannabis market, by derivatives, 2017 - 2030 (USD Million)
TABLE 8 North America legal cannabis market, by end-use, 2017 – 2030 (USD Million)
TABLE 9 North America medical-use market, by medical condition, 2017 - 2030 (USD Million)
TABLE 10 U.S. legal cannabis market, by sources, 2017 - 2030 (USD Million)
TABLE 11 U.S. legal marijuana market, by product, 2017 - 2030 (USD Million)
TABLE 12 U.S. hemp market, by product, 2017 - 2030 (USD Million)
TABLE 13 U.S. legal cannabis market, by derivatives, 2017 - 2030 (USD Million)
TABLE 14 U.S. legal cannabis market, by end-use, 2017 - 2030 (USD Million)
TABLE 15 U.S. medical-use market, by medical condition, 2017 - 2030 (USD Million)
TABLE 16 Canada legal cannabis market, by sources, 2017 - 2030 (USD Million)
TABLE 17 Canada legal marijuana market, by product, 2017 - 2030 (USD Million)
TABLE 18 Canada hemp market, by product, 2017 - 2030 (USD Million)
TABLE 19 Canada legal cannabis market, by derivatives, 2017 - 2030 (USD Million
TABLE 20 Canada legal cannabis market, by end-use, 2017 - 2030 (USD Million)
TABLE 21 Canada medical-use market, by medical condition, 2017 - 2030 (USD Million)


List of Figures

FIG. 1 Various stages of the research workflow
FIG. 2 Information procurement
FIG. 3 Market Formulation & Validation
FIG. 4 North America Legal Cannabis Market snapshot, 2021 (USD Million)
FIG. 5 North America Legal Cannabis Market segmentation
FIG. 6 Penetration & growth prospect mapping for end-use type, 2021
FIG. 7 Market driver relevance analysis (Current & future impact)
FIG. 8 North America Legal Cannabis Market restraints impact
FIG. 9 Number of clinical trials, by country
FIG. 10 The state-wise legalization scenario in the U.S
FIG. 11 Consumption of cannabis oil for oral use
FIG. 12 Percentage of respondents using cannabis edible products and those using products other than edibles
FIG. 13 North America Legal Cannabis Market, source type outlook: Key takeaways
FIG. 14 North America Legal Cannabis Market: source type movement analysis (2021 & 2030) (USD Million)
FIG. 15 Hemp market estimates and forecasts, 2017 - 2030 (USD Million)
FIG. 16 Hemp CBD market estimates and forecasts, 2017 - 2030 (USD Million
FIG. 17 Supplements market estimates and forecasts, 2017 - 2030 (USD Million)
FIG. 18 Industrial hemp market estimates and forecasts, 2017 - 2030 (USD Million)
FIG. 19 Marijuana market estimates and forecasts, 2017 - 2030 (USD Million)
FIG. 20 Flower market estimates and forecasts, 2017 - 2030 (USD Million)
FIG. 21 Oil and tinctures market estimates and forecasts, 2017 - 2030 (USD Million)
FIG. 22 North America Legal Cannabis Market, derivatives outlook: Key takeaways
FIG. 23 North America Legal Cannabis Market: derivatives type movement analysis (2021 & 2030) (USD Million)
FIG. 24 CBD market estimates and forecasts, 2017 - 2030 (USD Million)
FIG. 25 THC market estimates and forecasts, 2017 - 2030 (USD Million)
FIG. 26 Others market estimates and forecasts, 2017 - 2030 (USD Million)
FIG. 27 North America Legal Cannabis Market, end-use outlook: Key takeaways
FIG. 28 North America Legal Cannabis Market: End-use movement analysis (2020 & 2030)
FIG. 29 Recreational use market estimates and forecasts, 2017 - 2030 (USD Million)
FIG. 30 Medical use market estimates and forecasts, 2017 - 2030 (USD Million)
FIG. 31 Chronic pain market estimates and forecasts, 2017 - 2030 (USD Million)
FIG. 32 Cancer market estimates and forecasts, 2017 - 2028 (USD Million)
FIG. 33 Depression and anxiety market estimates and forecasts, 2017 - 2030 (USD Million)
FIG. 34 Arthritis market estimates and forecasts, 2017 - 2030 (USD Million)
FIG. 35 Diabetes market estimates and forecasts, 2017 - 2030 (USD Million)
FIG. 36 Glaucoma market estimates and forecasts, 2017 - 2030 (USD Million)
FIG. 37 Migraines market estimates and forecasts, 2017 - 2030 (USD Million)
FIG. 38 Epilepsy market estimates and forecasts, 2017 - 2030 (USD Million)
FIG. 39 Multiple Sclerosis market estimates and forecasts, 2017 - 2030 (USD Million)
FIG. 40 AIDS market estimates and forecasts, 2017 - 2030 (USD Million)
FIG. 41 ALS market estimates and forecasts, 2017 - 2030 (USD Million)
FIG. 42 Alzheimer’s market estimates and forecasts, 2017 - 2030 (USD Million)
FIG. 43 PTSD market estimates and forecasts, 2017 - 2030 (USD Million)
FIG. 44 Parkinson’s market estimates and forecasts, 2017 – 2030 (USD Million)
FIG. 45 Tourette’s market estimates and forecasts, 2017 - 2030 (USD Million)
FIG. 46 Others market estimates and forecasts, 2017 - 2030 (USD Million)
FIG. 47 Industrial use market estimates and forecasts, 2017 - 2030 (USD Million)
FIG. 48 Regional marketplace: Key takeaways
FIG. 49 North America Legal Cannabis Market: Regional movement analysis (2021 & 2030)
FIG. 50 North America Legal Cannabis Market estimates and forecasts, 2017 - 2030 (USD Million)
FIG. 51 U.S. Legal Cannabis Market estimates and forecasts, 2017 - 2030 (USD Million)
FIG. 52 Canada Legal Cannabis Market estimates and forecasts, 2017 - 2030 (USD million)
FIG. 53 Company market position analysis
FIG. 54 Recent Developments & Impact Analysis, By Key Market Participants

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

cog

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

BBB icon gvr sidebar D&B icon gvr sidebar

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.